Cipla Lauches Antibody Cocktail For Covid-19 Treatment; Shares Subdued

"Roche India and Cipla today announced that the first batch of the Antibody Cocktail (Casirivimab and Imdevimab) is now available in India," Cipla said in a regulatory filing to the stock exchanges

from NDTV Profit - Latest https://ift.tt/3yDfsYf
via